NCT02877069已完成4 期
A Prospective, Single-arm Study of the Safety and Effectiveness of VYC-12 Hyaluronic Acid Injectable Gel for Treatment of Superficial Cutaneous Depressions Such as Fine Lines and for Improvement of Skin Quality
适应症
干预措施
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- Allergan
- 入组人数
- 134
- 试验地点
- 1
- 主要终点
- Percentage of Participants with a ≥1 Point Improvement in the 5-Point Allergan Skin Roughness Scale (ASRS) compared to Baseline
研究概览
简要总结
This study will evaluate the safety and effectiveness of VYC-12 hyaluronic acid (HA) injectable gel for filling fine lines, as measured by skin texture improvement, and for improvement of skin quality.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Participants in good general health
- •Score of 2=Moderate (coarse and uneven visual skin texture) or 3=Severe (coarse visual skin texture, crosshatched fine lines) on both cheeks using the 5-Point Allergan Skin Roughness Scale (ASRS).
排除标准
- •Has undergone tissue augmentation with dermal fillers including HA, calcium hydroxylapatite, autologous fat, mesotherapy, or other cosmetic procedures (eg. face-lift, laser, photomodulation, intense pulsed light, radiofrequency, dermabrasion, chemical peel, or other ablative procedures) in the face or neck within the past 12 months
- •Has received any crosslinked HA filler in any anatomic area within the past 12 months
- •Has undergone treatment with botulinum toxins in the face or neck within the past 6 months
- •Has ever received semi-permanent fillers or permanent facial implants (eg. poly-L-lactic acid, polymethylmethacrylate, silicone, expanded polytetrafluoroethylene) anywhere in the face or neck
- •Has facial hair that would interfere with the visualization of the face or neck
- •Has undergone a dental procedure within the past 6 weeks
- •Has a tendency to develop hypertrophic scarring
- •Has a history of allergy to HA products and/or to gram-positive bacterial proteins as HA is produced by Streptococcus-type bacteria
- •Has a history of anaphylactic shock
- •Has been previously diagnosed with streptococcal disease (eg. recurrent sore throat, acute rheumatic fever)
- •Has current cutaneous inflammatory or infectious processes (eg. acne, herpes), abscess, an unhealed wound, or a cancerous or precancerous lesion on the face or neck
- •Is on an ongoing regimen of anticoagulation therapy (eg. warfarin)
- •Is on an ongoing regimen of medications (eg. aspirin, ibuprofen) or other substances (eg, herbal supplements with garlic, gingko biloba, or ginseng) known to increase coagulation time within 10 days of undergoing study device injection
- •Has begun using any over-the-counter or prescription, oral or topical, antiwrinkle products on the face or neck within the past 30 days.
研究组 & 干预措施
VYC-12 Injectable Gel
Experimental
VYC-12 Hyaluronic Acid (HA) injectable gel administered as an intradermal injection on Day 0 in the face and if applicable neck areas. Participants are eligible to receive up to 3 treatments including an optional top-up and an optional second treatment.
干预措施: VYC-12 HA injectable gel (Device)
结局指标
主要结局
Percentage of Participants with a ≥1 Point Improvement in the 5-Point Allergan Skin Roughness Scale (ASRS) compared to Baseline
时间窗: Baseline, Month 1
次要结局
- Change from Baseline in Instrument Measures of Cheek Skin Elasticity(Baseline, Month 1)
- Change from Baseline in Instrument Measures of Cheek Skin Smoothness(Baseline, Month 1)
- Change from Baseline in Instrument Measures of Cheek Skin Hydration(Baseline, Month 1)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
A Study of Hyaluronic Acid Injectable Gel (VYC-25L) for Restoration and Creation of Facial Volume in the Chin and JawChin RetrusionNCT02559908Allergan120
已完成
1 期
Periocular Rejuvenation by Topical Hyaluronic Acid Nano ParticlesDark EyelidsTear Trough Eyelid DeformityWrinkleNCT05742399Alexandria University30
已完成
不适用
Performance and Safety of Hyalo Gyn Gel on the Treatment of Vaginal Atrophy in Postmenopausal WomenVulvovaginal AtrophyNCT04355403Fidia Farmaceutici s.p.a.80
Unknown
不适用
ltrasound-guided Hyaluronic acid injection in Trapeziometarcarpal joint arthritis: a triple blind, randomised clinical trial of efficacy and safetyTrapeziometarcarpal joint arthritisTCTR20201221005lerdsin hospital60
已完成
不适用
Safety and Effectiveness of Monovisc® Injection for Osteoarthritis of the KneeOsteoarthritisNCT00653432Anika Therapeutics, Inc.369